Benjamin Abella of the School of Medicine comments on the importance of modernized CPR guidelines.
Health & Medicine
Dean Afaf Meleis of the School of Nursing discusses the role of nursing in health-care reform.
Taking a cue from the world of business-performance experts and baseball talent scouts, Penn Medicine translational medicine researchers are among the first to find a way to measure the productivity of collaborations in a young, emerging institute. They published their findings the most recent issue of Science Translational Medicine.
Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer’s disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer’s disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.
The Penn Heart Rescue Program is cited for its expansion among community hospitals.
Edna Foa of the School of Medicine discusses the mental trauma the rescued Chilean miners might face.
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions. Researchers at the University of Pennsylvania School of Medicine have identified the steps that control how different forms of an immune cell protein called CD45, which is critical for activating the immune system when faced with pathogens, are controlled in the arc of a body’s immune response.
Victor Galli and Leah Abrams, students in the School of Arts Sciences, and Ian Penkala, a student in the School of Engineering and Applied Science, discuss Penn’s vegetarian dining options.
As the public’s awareness of sport-related head injuries continues to grow, athletic trainers in college sports programs could be at risk of lawsuits. So says Steve Pachman, a lawyer at Montgomery McCracken Walker & Rhoads, a Philadelphia law firm.
The University of Pennsylvania’s Abramson Cancer Center has been rated as “exceptional” by the National Cancer Institute (NCI) during a competitive research funding review by the government agency.